InvestorsHub Logo

RLSJ84

07/03/16 8:07 PM

#208919 RE: jour_trader #208916

Thanks. I assumed that's what you meant but didn't want to ASSume. I'm pretty sure that any number north of $2-3 would be his "number" even though that is in my opinion wildly undervalued. But hey that's even a nice pay day for the longs. What would be even better for everyone would be if sequestox got approved with ADF labeling and then Embeda did not get approved with labeling. Then Pfizer might be willing to jump on ELTP for sure. Speculative but very possible.

NASDAQ2020

07/03/16 9:42 PM

#208926 RE: jour_trader #208916

Nasrat knows when the best window is for buyout.